RestoLife Molecules

RestoLife Molecules is an early-stage biotechnology company focused on developing small molecule therapeutics that target the underlying biological mechanisms of aging and age-related diseases. The company's research centers on the NAD+ biosynthetic pathway and the activation of sirtuins to enhance cellular health and longevity. By modulating these metabolic regulators, RestoLife aims to address a broad spectrum of conditions, including metabolic syndrome, neurodegeneration, and cardiovascular decline. The firm leverages expertise in medicinal chemistry and molecular biology to identify novel compounds with improved bioavailability and potency compared to existing longevity supplements.